Patents by Inventor Arun Richard Chandrasekaran

Arun Richard Chandrasekaran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250034619
    Abstract: Provided herein are nucleic acid-based nanoswitches that can detect specific nucleic acids and other analytes types by for example a simple gel electrophoresis readout. Binding of the target to the nanoswitches induces a conformation change from a linear, open conformation to a looped, closed conformation. These nanoswitches may be used in diagnostic assays such as nucleic acid-based diagnostic assays, to detect, measure and/or purify a variety of targets including low abundance targets.
    Type: Application
    Filed: August 7, 2024
    Publication date: January 30, 2025
    Applicants: The Research Foundation for The State University of New York, Children's Medical Center Corporation
    Inventors: Arun Richard Chandrasekaran, Clinton H. Hansen, Mounir Ahmad Koussa, Kenneth Anders Halvorsen, Wesley Philip Wong
  • Patent number: 12077807
    Abstract: Provided herein are nucleic acid-based nanoswitches that can detect specific nucleic acids and other analytes types by for example a simple gel electrophoresis readout. Binding of the target to the nanoswitches induces a conformation change from a linear, open conformation to a looped, closed conformation. These nanoswitches may be used in diagnostic assays such as nucleic acid-based diagnostic assays, to detect, measure and/or purify a variety of targets including low abundance targets.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: September 3, 2024
    Assignees: The Research Foundation for The State University of New York, Children's Medical Center Corporation
    Inventors: Arun Richard Chandrasekaran, Clinton H. Hansen, Mounir Ahmad Koussa, Kenneth Anders Halvorsen, Wesley Philip Wong
  • Publication number: 20220220536
    Abstract: The present disclosure is directed to a nucleic acid, including: a DNA nanoswitch-nucleic acid complex including a deoxyribonucleic acid (DNA) nanoswitch and a ribonucleic acid binding site, wherein the DNA nanoswitch has a first conformation characterized as open, and a second conformation characterized as closed when in a presence of ribonucleic acid-of-interest. DNA nanoswitches that hybridize to preselected viral RNA are also disclosed, as well as methods of detecting or identifying an RNA virus, and kits related thereto.
    Type: Application
    Filed: January 11, 2022
    Publication date: July 14, 2022
    Inventors: Kenneth A. Halvorsen, Lifeng Zhou, Arun Richard Chandrasekaran
  • Publication number: 20220026429
    Abstract: The present disclosure is directed to a polynucleotide capable of signaling under preselected conditions. For example, the present disclosure relates to a method of reconfiguring a nucleic acid or polynucleotide, including: contacting a deoxyribonucleic acid (DNA) nanoswitch and nucleic acid to form a DNA nanoswitch-nucleic acid complex having a first conformation, wherein the first conformation is characterized as locked; contacting the DNA nanoswitch-nucleic acid complex with a biological specimen to form a mixture, wherein when the nucleic acid is ribonucleic acid (RNA) and the biological specimen includes one or more ribonucleases, the first conformation changes to a second conformation characterized as open; processing the mixture under conditions sufficient to separate the first conformation, and when present, the second conformation; and reacting the first conformation, and when present, the second conformation with an indicator under conditions sufficient to form a signal.
    Type: Application
    Filed: July 21, 2021
    Publication date: January 27, 2022
    Inventors: Kenneth Anders Halvorsen, Arun Richard Chandrasekaran
  • Publication number: 20180223344
    Abstract: Provided herein are nucleic acid-based nanoswitches that can detect specific nucleic acids and other analytes types by for example a simple gel electrophoresis readout. Binding of the target to the nanoswitches induces a conformation change from a linear, open conformation to a looped, closed conformation. These nanoswitches may be used in diagnostic assays such as nucleic acid-based diagnostic assays, to detect, measure and/or purify a variety of targets including low abundance targets.
    Type: Application
    Filed: June 27, 2016
    Publication date: August 9, 2018
    Inventors: Arun Richard Chandrasekaran, Clinton H. Hansen, Mounir Ahmad Koussa, Kenneth Anders Halvorsen, Wesley Philip Wong